Steiner G, Studnicka-Benke A, Witzmann G, Höfler E, Smolen J
Ludwig Boltzmann Institute for Rheumatology and Balneology, Lainz Hospital, Vienna, Austria.
J Rheumatol. 1995 Mar;22(3):406-12.
To compare levels of soluble tumor necrosis factor receptor (TNF-R) and soluble interleukin 2 receptor (sIL-2R) in sera and synovial fluids (SF) of patients with rheumatoid arthritis (RA), reactive arthritis (ReA), and osteoarthritis (OA) in order to investigate the usefulness of soluble cytokine receptors for differentiation diagnosis and their involvement in the pathophysiology of rheumatic diseases.
Soluble TNF-R (55 kDa), sIL-2R, and TNF-alpha were measured by ELISA in sera and SF of patients with RA, ReA, and OA and correlated with serological and clinical disease activity variables.
Serum TNF-R was significantly (p < 0.0001) elevated in RA (4.6 +/- 2.1 ng/ml, mean +/- SD) compared to ReA (2.5 +/- 0.6 ng/ml), OA (2.2 +/- 0.7 ng/ml), and healthy controls (2.0 +/- 0.4 ng/ml). In SF mean TNF-R levels were 21 +/- 9.3 ng/ml in RA, 12.5 +/- 5.1 ng/ml in ReA, and 8.7 +/- 3.7 ng/ml in OA (p < 0.0001 for RA vs ReA or OA; p < 0.02 for ReA vs OA). SF levels were significantly higher in rheumatoid factor (RF) positive than in RF negative patients with RA. In patients with RA, correlations were found between TNF-R and TNF-alpha in SF (r = 0.32, p < 0.01), and between TNF-R and early morning stiffness (r = 0.4, p < 0.003 in serum; r = 0.29, p < 0.05 in SF). However, there was no correlation with disease activity variables such as Ritchie index, erythrocyte sedimentation rate (ESR) or C-reactive protein. Serum levels of IL-2R were elevated in RA and ReA, but a significant difference was found only for RA versus OA and controls (p < 0.0005), whereas in SF significant differences existed between all 3 patient groups (RA/ReA: p < 0.004; RA/OA: p < 0.0001; ReA/OA: p < 0.0003); both in serum and SF, levels of RF positive patients with RA were higher than those of RF negative patients. In patients with RA, IL-2R correlated weakly with ESR (r = 0.24, p < 0.05), iron concentration (r = -0.35, p < 0.005), and CRP (r = 0.24, p < 0.05).
In RA, in contrast to ReA and OA, TNF-R and IL-2R were not only elevated in the joint fluid but also in serum. This indicates general activation of the immune system in RA, but not in ReA and OA. Therefore the soluble receptors, especially TNF-R, might become useful diagnostic variables to distinguish RA from ReA and OA.
比较类风湿关节炎(RA)、反应性关节炎(ReA)和骨关节炎(OA)患者血清及滑膜液(SF)中可溶性肿瘤坏死因子受体(TNF-R)和可溶性白细胞介素2受体(sIL-2R)的水平,以研究可溶性细胞因子受体在鉴别诊断中的作用及其在风湿性疾病病理生理学中的参与情况。
采用酶联免疫吸附测定法(ELISA)检测RA、ReA和OA患者血清及SF中的可溶性TNF-R(55 kDa)、sIL-2R和TNF-α,并与血清学及临床疾病活动变量进行相关性分析。
与ReA(2.5±0.6 ng/ml)、OA(2.2±0.7 ng/ml)和健康对照(2.0±0.4 ng/ml)相比,RA患者血清TNF-R显著升高(4.6±2.1 ng/ml,均值±标准差,p<0.0001)。在SF中RA患者的平均TNF-R水平为21±9.3 ng/ml,ReA患者为12.5±5.1 ng/ml,OA患者为8.7±3.7 ng/ml(RA与ReA或OA相比,p<0.0001;ReA与OA相比,p<0.02)。类风湿因子(RF)阳性的RA患者SF水平显著高于RF阴性患者。在RA患者中,SF中TNF-R与TNF-α之间存在相关性(r = 0.32,p<0.01),血清中TNF-R与晨僵之间存在相关性(r = 0.4,p<0.003;SF中r = 0.29,p<0.05)。然而,与疾病活动变量如里奇指数、红细胞沉降率(ESR)或C反应蛋白无相关性。RA和ReA患者血清IL-2R水平升高,但仅RA与OA及对照组之间存在显著差异(p<0.0005),而在SF中,三组患者之间均存在显著差异(RA/ReA:p<0.004;RA/OA:p<0.0001;ReA/OA:p<0.0003);在血清和SF中,RF阳性的RA患者水平均高于RF阴性患者。在RA患者中,IL-2R与ESR(r = 0.24,p<0.05)、铁浓度(r = -0.35,p<0.005)和CRP(r = 0.24,p<0.05)呈弱相关性。
与ReA和OA不同,RA患者不仅关节液中TNF-R和IL-2R升高,血清中亦升高。这表明RA患者免疫系统普遍激活,而ReA和OA患者则不然。因此,可溶性受体,尤其是TNF-R,可能成为区分RA与ReA和OA的有用诊断变量。